Hologic
HOLX · NASDAQ
Price unavailable right now.
No price history for this range.
EPS: actual vs estimate
Beat the estimate in 3 of the last 8 quarters, by 2.1% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q1 FY26 | $1.11 | $1.04 | −6.4% |
| Q3 FY25 | $1.12 | $1.13 | +0.7% |
| Q4 FY25 | $1.11 | $1.04 | −6.4% |
| Q2 FY25 | $1.04 | $1.03 | −0.6% |
| Q1 FY25 | $1.04 | $1.03 | −0.6% |
| Q4 FY24 | $1.03 | $1.01 | −2.3% |
| Q3 FY24 | $1.04 | $1.06 | +2.3% |
| Q2 FY24 | $0.9971 | $1.03 | +3.3% |
Earnings calls
- Morgan Stanley 23rd Annual Global Healthcare Conference
- HOLX - Earnings call Q3 2025
- Jefferies Global Healthcare Conference 2025
- 45th Annual William Blair Growth Stock Conference
- RBC Capital Markets Global Healthcare Conference 2025
- HOLX - Earnings call Q2 2025
- Raymond James & Associates’ 46th Annual Institutional Investors Conference 2025
- HOLX - Earnings call Q1 2025
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.